Weakness across the major banks and some heavyweight health stocks contributed to the Australian share market’s falls last week.
The benchmark S&P/ASX 200 dropped 0.45% to 6,175 points, while the broader All Ordinaries index fell 0.35% to close at 6,265 points last week.
The major banks closed lower, with three of the big four dominating market value losses, while the healthcare sector was partly weighed down by stocks trading ex-dividend.
ANZ led losses, with its market value falling by $2.2 billion after its shares ended last week 2.8% lower at $26.35. Its weak performance was partly due to a broker downgrade on Friday, CommSec analysts say.
Canstar’s Group Executive of Financial Services Steve Mickenbecker said a downgrading of economic growth expectations has weighed on bank share prices.
“This adds to the headwinds of slowing demand for housing, tougher regulatory standards, implementation cost and restraint of the banking royal commission’s recommendations and potential for class actions,” Mr Mickenbecker said.
“A further slowing in demand for housing and business credit will hurt revenue and there is the prospect of the first blowout in bad debts in several years.”
Among the stocks to trade ex-dividend last week was biotech giant CSL and aged care operator Regis Healthcare, with the former shedding $1.6 billion in market value.
ASX 200 Listed Companies – Top 5 Biggest Market Cap Gains and Losses (08/03/2019 to 15/03/2019) | |||||||||
Biggest Gains | Biggest Losses | ||||||||
Rank | Company | $ Change in Market Cap | Closing Share Price | % Change in Share Price | Rank | Company | $ Change in Market Cap | Closing Share Price | % Change in Share Price |
1 | WiseTech Global (WTC) | $605,187,694 | $22.49 | 9.8% | 1 | ANZ Banking (ANZ) | -$2,191,411,922 | $26.35 | -2.8% |
2 | Telstra Corporation (TLS) | $475,731,914 | $3.26 | 1.2% | 2 | Westpac Banking (WBC) | -$1,723,785,512 | $26.48 | -1.9% |
3 | RIO Tinto (RIO) | $389,777,025 | $91.65 | 1.2% | 3 | CSL (CSL) | -$1,556,019,202 | $195.93 | -1.7% |
4 | Stockland (SGP) | $336,733,340 | $3.81 | 3.8% | 4 | Commonwealth Bank (CBA) | -$1,540,108,371 | $72.31 | -1.2% |
5 | Transurban (TCL) | $321,035,801 | $12.65 | 1.0% | 5 | BHP (BHP) | -$1,178,340,558 | $36.48 | -1.1% |
Prepared by Canstar. Prices taken as of week to week close. |
Weaker base metal prices contributed to a slide in BHP’s shares, while Rio Tinto fared better and finished the week higher.
AMP Capital Chief Economist Shane Oliver said global markets rebounded last week, while the local market fell with consumer and financial shares down on worries about the domestic economy.
Dr Oliver said the Australian 10-year bond yield also dropped below 2% for the first time in about three years as weakening economic data added to expectations for RBA rate cuts.
“Australian data was soft over the last week with falls in business confidence, consumer confidence and housing finance,” he said.
“The ongoing fall in housing finance indicates that tight credit conditions are continuing.”
ASX 200 Listed Companies – Top 5 Biggest Share Price Gains and Losses (08/03/2019 to 15/03/2019) | |||||||
Biggest Gains | Biggest Losses | ||||||
Rank | Company | Closing Share Price | % Change | Rank | Company | Closing Share Price | % Change |
1 | WiseTech Global (WTC) | $22.49 | 9.8% | 1 | Sigma Health (SIG) | $0.53 | -14.6% |
2 | Saracen Mineral (SAR) | $2.79 | 8.6% | 2 | Ardent Leisure (ALG) | $1.27 | -13.3% |
3 | Bellamy’s Australia (BAL) | $11.20 | 8.2% | 3 | Seven West Media (SWM) | $0.50 | -7.4% |
4 | Perpetual (PPT) | $41.59 | 8.1% | 4 | Infigen Energy (IFN) | $0.47 | -7.0% |
5 | St Barbara (SBM) | $4.50 | 7.9% | 5 | Syrah Resources (SYR) | $1.08 | -6.9% |
Prepared by Canstar. Prices taken as of week to week close. |
Logistics software company WiseTech Global was the market’s strongest performer last week, with its shares jumping by nearly 9% to $22.49 and its market value growing by more than $600 million.
Meanwhile, property group Stockland was among the top five winners when it came to overall value gains.
News coming out of Stockland last week was that it will sell more of its shopping and commercial centres in Brisbane, which the company said it considered as “non-core” retail assets.
This advice is general and has not taken into account your objectives, financial situation, or needs. It is not personal advice. Consider whether this advice is right for you, having regard to your own objectives, financial situation and needs. You may need financial advice from a suitably qualified adviser. For more information, read Canstar’s Financial Services and Credit Guide (FSCG) and our detailed disclosure. Canstar may receive a fee for referring you to a product provider – for further information, see how we get paid.
Canstar is a comparison website, not a product issuer, so it’s important to check any product information directly with the provider. Consider the Product Disclosure Statement (PDS), Target Market Determination (TMD) and other applicable product documentation before making a decision to purchase, acquire, invest in or apply for a financial or credit product. Contact the product issuer directly for a copy of the PDS, TMD and other documentation.
Canstar is an information provider and in giving you product information Canstar is not making any suggestion or recommendation about a particular credit product or loan. If you decide to apply for a credit product or loan, you will deal directly with a credit provider, and not with Canstar. Rates and product information should be confirmed with the relevant credit provider. For more information, read the credit provider’s key facts sheet and other applicable loan documentation for that product. Read the Comparison Rate Warning.
All information about performance returns is historical. Past performance should not be relied upon as an indicator of future performance; unit prices and the value of your investment may fall or rise.
Canstar is an information provider and in giving you product information Canstar is not making any suggestion or recommendation about a particular product. The information has been prepared without taking into account your individual investment objectives, financial circumstances or needs. Before you decide whether or not to acquire a particular financial product you should assess whether it is appropriate for you in the light of your own personal circumstances, having regard to your own objectives, financial situation and needs. You may wish to obtain financial advice from a suitably qualified adviser before making any decision to acquire a financial product. Please refer to the product disclosure statement (PDS) and Canstar’s Financial Services and Credit Guide (FSCG) for more information, and read our detailed disclosure, important notes and liability disclaimer.
All information about performance returns is historical. Past performance should not be relied upon as an indicator of future performance; unit prices and the value of your investment may fall or rise.
Canstar may earn a fee for referrals from its website tables, and from Sponsorship or Promotion of certain products. Fees payable by product providers for referrals and Sponsorship or Promotion may vary between providers, website position, and revenue model. Sponsorship or Promotion fees may be higher than referral fees. Sponsored or Promotion products are clearly disclosed as such on website pages. They may appear in a number of areas of the website such as in comparison tables, on hub pages and in articles. Sponsored or Promotion products may be displayed in a fixed position in a table, regardless of the product's rating, price or other attributes. The table position of a Sponsored or Promoted product does not indicate any ranking or rating by Canstar. For more information please see How We Get Paid.
Any advice provided on this website is general and has not taken into account your objectives, financial situation or needs. Consider whether this advice is right for you. Consider the Product Disclosure Statement and Target Market Determination before making a purchase decision. Canstar provides an information service. It is not a credit provider, and in giving you information about credit products Canstar is not making any suggestion or recommendation to you about a particular credit product. Research provided by Canstar Research AFSL and Australian Credit Licence No. 437917. You must not reproduce, transmit, disseminate, sell, or publish information on this website without prior written permission from Canstar.